Quote:
Originally posted by Bad_Rich_Chic
That said, most innovation in the US system is in ... well, elder care generally and end of life care specifically, because that's where the money is. Which means the innovation is of limited benefit to the rest of us, so I'm not sure how I'd weigh its loss.
|
If I had to identify the most significant innovations today, I'd say they are in genetics and the development of genetic therapies, certainly not something limited to the elderly, and in medical information systems, especially "expert systems" screening software, also not limited to the elderly. We're now getting past the age of pharacological innovation, and while a lot of money is spent on oncology and cardiac care, I don't think we're getting enormous innovation in either area today (maybe 10 years ago, but today its mostly incremental change in those areas, like drug coated stents).
